Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Sponsor
Pharmacia (Industry)
Overall Status
Completed
CT.gov ID
NCT00002267
Collaborator
(none)
750
43
17.4

Study Details

Study Description

Brief Summary

The primary objective of this trial is to assess the safety and the relative benefit of rifabutin monotherapy in preventing or delaying the incidence of Mycobacterium avium complex (MAC) bacteremia in AIDS patients with CD4 counts less than or equal to 200, as compared to placebo, and to assess if survival is prolonged in patients who receive rifabutin prophylaxis.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria

    Patients must have the following:
    • Diagnosis of AIDS with a case defining infection other than Mycobacterium avium complex (MAC).

    • Written informed consent obtained, which must include a statement that treatment may involve risks to the embryo or fetus, which are currently unforeseeable, if the subject becomes pregnant.

    Exclusion Criteria

    Co-existing Condition:
    Patients with the following conditions or symptoms are excluded:
    • Known hypersensitivity to rifabutin, rifampin, other rifamycins, zidovudine or didanosine (ddI).

    • Previous or current infection due to Mycobacterium avium complex (MAC) disease as evaluated by two successive blood cultures and two successive stool cultures taken within 14 days prior to study initiation.

    Concurrent Medication:
    Excluded:
    • Antiretroviral agents other than zidovudine (AZT).

    • Didanosine (ddI).

    • Antimycobacterial therapy.

    • Rifampin.

    • Isoniazid.

    • Clofazimine.

    • Ethambutol.

    • Cycloserine.

    • Ethionamide.

    • Amikacin.

    • Ciprofloxacin.

    • Streptomycin.

    • Other investigational drugs.

    • If antimicrobial therapy is required to treat bacterial infections (= or < 14 days), Adria Laboratories must be contacted prior to initiation of therapy.

    Patients with the following are excluded:
    • Known hypersensitivity to rifabutin, rifampin, other rifamycins, zidovudine (AZT), or didanosine (ddI).

    • Previous or current Mycobacterium avium complex (MAC) infection.

    • Perceived patient unreliability or unavailability for frequent monitoring.

    Prior Medication:
    Excluded within 4 weeks of study entry:
    • Antiretroviral agents other than zidovudine (AZT) or didanosine (ddI).

    • Antimycobacterial therapy.

    • Rifampin.

    • Isoniazid.

    • Clofazimine.

    • Ethambutol.

    • Cycloserine.

    • Ethionamide.

    • Amikacin.

    • Ciprofloxacin.

    Required:
    • Zidovudine (AZT).

    • Antipneumocystis prophylactic therapy.

    Required for at least 4 weeks prior to study entry:
    • Zidovudine (AZT) or didanosine (ddI).

    • Antipneumocystis prophylaxis.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Maricopa County Med Ctr Phoenix Arizona United States 85010
    2 East Bay AIDS Ctr Berkeley California United States 94704
    3 Pacific Oaks Med Group Beverly Hills California United States 90211
    4 AIDS Community Research Consortium Redwood City California United States 94063
    5 HIV Research Group San Diego California United States 92102
    6 Dr Larry A Waites San Francisco California United States 94108
    7 Saint Francis Mem Hosp / HIV Care San Francisco California United States 94109
    8 Dr Marcus Conant San Francisco California United States 94115
    9 San Francisco Veterans Administration Med Ctr San Francisco California United States 94121
    10 Dr Marshall Kubota Santa Rosa California United States 95404
    11 Dr Jeffrey Galpin Tarzana California United States 91356
    12 Miami Veterans Administration Med Ctr Miami Florida United States 33125
    13 Community Research Initiative of South Florida Miami Florida United States 33137
    14 Northwestern Univ Med School Chicago Illinois United States 60611
    15 AIDS Research Alliance - Chicago Chicago Illinois United States 60657
    16 Tulane Univ School of Medicine New Orleans Louisiana United States 70112
    17 Comprehensive AIDS Alliance of Detroit / Harper Hosp Detroit Michigan United States 48201
    18 Univ of Minnesota Minneapolis Minnesota United States 55455
    19 St Paul Ramsey Med Ctr St Paul Minnesota United States 55101
    20 Univ of Nevada / Veterans Administration Med Ctr Reno Nevada United States 89520
    21 North Jersey Community Research Initiative Newark New Jersey United States 071032842
    22 Univ of New Mexico Hlth Sciences Ctr / Dept of Med Albuquerque New Mexico United States 87131
    23 Dr Donald Romig Sante Fe New Mexico United States 87501
    24 Albany Veterans Administration Albany New York United States 12208
    25 AIDS Services Erie County Med Ctr Buffalo New York United States 14215
    26 Community Health Network Rochester New York United States 14620
    27 Buckley Braffman Stern Med Associates Philadelphia Pennsylvania United States 19107
    28 Thomas Jefferson Med College Philadelphia Pennsylvania United States 19107
    29 Dr Alfred F Burnside Jr Columbia South Carolina United States 29204
    30 Infectious Disease Physicians Inc Annandale Virginia United States 22203
    31 Milwaukee County Med Complex Milwaukee Wisconsin United States 53226
    32 Univ of Calgary Health Science Ctr Calgary Alberta Canada
    33 Univ of Alberta/Division of Inf Dis/Dept of Med Edmonton Alberta Canada
    34 Saint Paul's Hosp Vancouver British Columbia Canada
    35 Victoria Gen Hosp Halifax Nova Scotia Canada
    36 McMaster Univ Med Ctr Hamilton Ontario Canada
    37 Ottawa Gen Hosp Ottawa Ontario Canada
    38 Mount Sinai Hosp Toronto Ontario Canada
    39 Saint Michael's Hosp Toronto Ontario Canada
    40 Sunnybrook Health Science Ctr Toronto Ontario Canada
    41 Dr Emil Toma / Hotel Dieu de Montreal Montreal Quebec Canada
    42 Montreal Chest Institute Montreal Quebec Canada
    43 Montreal Gen Hosp Montreal Quebec Canada

    Sponsors and Collaborators

    • Pharmacia

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00002267
    Other Study ID Numbers:
    • 048B
    • 087027-999
    First Posted:
    Aug 31, 2001
    Last Update Posted:
    Jun 24, 2005
    Last Verified:
    Mar 1, 1992

    Study Results

    No Results Posted as of Jun 24, 2005